Recent market growth is driven by advancements in understanding disease mechanics, targeted therapies like tolvaptan (Jynarque), and increased diagnosis rates. Tolvaptan, approved by the FDA, marks a ...

New research is uncovering how medications targeting the glucagon-like peptide-1 (GLP-1) system affect brain circuits involved in nausea, thirst, and pleasurable behaviors. These findings will be ...

Researchers transplanted a single-edit α-Gal knockout pig kidney and thymus into a brain-dead recipient, followed by 61 days ...

“At night, the bladder’s stretch receptors become quieter. This means the same volume of urine feels less urgent compared to ...

Heart failure is a complex clinical syndrome affecting around 70 million individuals globally. It has a prevalence of 2% in ...

No discussion of fluid movement is complete without highlighting the vital role of electrolytes. These charged minerals, ...